Y-Biologics, Inc. (KOSDAQ:338840)
South Korea
· Delayed Price · Currency is KRW 23,150
-550 (-2.32%)
At close: Apr 28, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 351.37 billion as of April 29, 2026. Its market cap has increased by 307.71% in one year.
Market Cap
351.37B
Enterprise Value
321.86B
Revenue
2.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
23,150.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has increased from 177.50B to 351.37B, an increase of 97.96%. That is a compound annual growth rate of 32.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 351.37B | 1.09% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 386.56B |
| curacle co.,ltd. | 353.43B |
| S.Biomedics | 424.81B |
| HansBiomed | 430.69B |
| NIBEC | 314.32B |
| TiumBio | 308.23B |
| Bio Solution | 285.65B |
| Kanaph Therapeutics | 492.95B |